Pear Therapeutics exploring sale, other ‘strategic alternatives’ (MobiHealth News):
Prescription digital therapeutics company Pear Therapeutics is exploring “strategic alternatives,” including a possible company sale, merger or acquisition.
In a press release, the company said it hired a financial advisor to look into actions that could “maximize shareholder value.” That includes a potential sale, M&A, divestiture of assets, licensing or other strategic transactions. It may also seek additional financing. [Read more…] about Pear Therapeutics loses 97% of its market capitalization since 2021, explores strategic alternatives